Andrea Galisova

Title: Andrea Galisova: Innovator in Antitumor Compositions

Introduction

Andrea Galisova is a notable inventor based in Rybany, Slovakia. She has made significant contributions to the field of medical science, particularly in the development of antitumor compositions. Her innovative work focuses on utilizing hyaluronic acid and inorganic nanoparticles to create effective treatments for various types of cancer.

Latest Patents

Andrea Galisova holds a patent for an antitumor composition based on hydrophobized hyaluronan and inorganic nanoparticles stabilized by oleic acid. This invention relates to a composition that serves as a carrier for inorganic nanoparticles, which may include superparamagnetic nanoparticles and nanoparticles of ZnO. The composition has shown selective cytotoxic effects against both suspension and adherent tumor cell lines, particularly those associated with colorectal carcinoma, lung carcinoma, hepatocellular carcinoma, and breast adenocarcinoma. The highest cytotoxic effects were observed with the composition based on an oleyl derivative of hyaluronan combined with SPIONs. Additionally, this composition can be used for in vivo detection of accumulation in the body, especially in tumors or the liver, and is sterilizable in its final package.

Career Highlights

Andrea is currently employed at Contipro A.S., where she continues to advance her research and development efforts. Her work has positioned her as a key figure in the field of cancer treatment innovations.

Collaborations

Andrea collaborates with talented coworkers, including Daniela Smejkalova and Kristina Nesporova, who contribute to her research initiatives and help drive forward the development of new therapeutic solutions.

Conclusion

Andrea Galisova's innovative work in antitumor compositions highlights her commitment to advancing medical science and improving cancer treatment options. Her contributions are paving the way for future breakthroughs in the field.